S-1: Safety Shot Secures $1.75 Million Convertible Note from Bigger Capital LLC

Safety Shot, Inc. enters into a secured convertible note agreement with Bigger Capital LLC for $1.75 million to manage debt and facilitate potential equity conversions.

Summary

• Safety Shot, Inc. has entered into a secured convertible note agreement with Bigger Capital LLC for a principal sum of $1.75 million.
• The note carries an interest rate of 9% per annum, accruing from January 20, 2025.
• Bigger Capital LLC has the option to convert the outstanding principal and accrued interest into shares of Safety Shot's common stock.
• The conversion price is the lesser of $0.5435 per share or the Nasdaq Official Closing Price immediately preceding the date Stockholder Approval is obtained.
• The entire principal amount is due on December 31, 2026, unless earlier repaid or converted.
• The note includes provisions for adjustments to the conversion price in the event of stock dividends, splits, or fundamental transactions.
• Safety Shot has the right to prepay the note at 100% of the principal amount plus accrued interest until July 18, 2025, contingent on fulfilling obligations under an Unsecured Note.
• The note is secured by a first priority security interest in all of Safety Shot's assets.
• Events of default include failure to pay principal or interest, failure to deliver conversion shares, and breach of covenants.
• Upon an event of default, the outstanding amount becomes immediately due and payable at the Holder's election, either in cash or shares of Common Stock.

Sentiment

Score: 7

Explanation: The document is a standard financial agreement. The sentiment is neutral, reflecting a routine business transaction.

Positives

• The agreement provides Safety Shot with $1.75 million in funding.
• The convertible feature offers flexibility in managing debt and potential equity conversions.
• The prepayment option allows Safety Shot to manage its debt obligations strategically.
• The note is secured, providing Bigger Capital LLC with a strong position.

Negatives

• The note carries a 9% annual interest rate, increasing the company's financial obligations.
• Conversion of the note could dilute existing shareholders' equity.
• The note includes negative covenants that restrict the company's actions without the Holder's consent.
• Events of default can trigger immediate payment of the outstanding amount, potentially straining the company's finances.

Risks

• Failure to meet financial obligations under the note could lead to acceleration of debt and potential legal action.
• Dilution of existing shareholders' equity if the note is converted into common stock.
• Negative covenants restrict the company's ability to incur debt, create liens, or dispose of assets without the Holder's consent.
• The conversion price is subject to adjustment, potentially increasing the number of shares issued upon conversion.
• The company's ability to prepay the note is contingent on fulfilling obligations under an Unsecured Note.

Future Outlook

The company aims to obtain Stockholder Approval for the transactions contemplated under the Secured Convertible Note and other Transaction Documents, including the issuance of all of the shares of common stock issuable thereunder.

Industry Context

This type of financing is common for companies seeking capital, especially smaller companies. The convertible note structure allows for flexibility and potential upside for both the company and the investor.

Comparison to Industry Standards

• Comparable companies in the biotechnology and pharmaceutical industries often utilize convertible notes as a means of raising capital.
• The terms of this convertible note, including the interest rate and conversion price, are within the typical range for similar financings in the current market environment.
• For example, companies like Amyris and Ocugen have used convertible notes to fund operations and research and development.
• The specific terms of each note are negotiated based on the company's financial condition, growth prospects, and the overall market conditions.

Stakeholder Impact

• Existing shareholders may experience dilution if the note is converted into common stock.
• The company's financial flexibility may be limited by the negative covenants in the note agreement.
• Bigger Capital LLC, as the Holder, gains a secured position and potential upside through conversion rights.

Next Steps

• Safety Shot needs to obtain Stockholder Approval for the transactions contemplated under the Secured Convertible Note and other Transaction Documents.
• Bigger Capital LLC may elect to convert the note into shares of Safety Shot's common stock.
• Safety Shot may exercise its right to prepay the note before the Maturity Date.

Key Dates

Keywords

convertible note, Bigger Capital LLC, Safety Shot Inc., financing, debt, equity, conversion, interest rate, security interest, prepayment, default, stockholder approval